Search Share Prices
GSK Share Price - Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC
StockMarketWire.com - Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 1450p (from 1550p).
Vectura expects growth in 2020, “resilient” against coronavirus risks
The pharma company expects royalties and marketed revenues to grow by mid-single digit percentage in 2020, despite the loss of the annual £9mln royalty from GlaxoSmithKline PLC (LON:GSK) following a ...
Does GlaxoSmithKline plc's (LON:GSK) CEO Salary Reflect Performance?
since 2017. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at other big companies. Next, we'll consider growth that the business demonstrates. And ...
Human Papillomaviru Therapeutics Market 2020 Valuable Growth Prospects and Current Trends Analysis 2025
Major industry players with significant revenue share include Bausch Health BHC, +15.91%, GlaxoSmithKline (lon:GSK), Lee’s Pharmaceutical Holdings (hkg:0950), AbbVie ABBV, +8.60%, Perrigo Company, ...
What the F-Score says about Glaxosmithkline’s (LON:GSK) chunky dividend payment
Take Glaxosmithkline (LON:GSK), for example, which is a conservative company in the Healthcare sector. Glaxosmithkline pays out a rolling 5.28% of its share price in dividend payments. But sometimes a ...